Welcome to CDC Stacks | Poor Potential Coverage for 7-Valent Pneumococcal Conjugate Vaccine, Malawi - 14223 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Poor Potential Coverage for 7-Valent Pneumococcal Conjugate Vaccine, Malawi
  • Published Date:
    Jun 2003
  • Source:
    Emerg Infect Dis. 9(6):747-749.
Filetype[PDF - 194.17 KB]


Details:
No Related Documents.
You May Also Like:
  1. Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
    Personal Author:
    van Deursen, Anna M.M.; van Mens, Suzan P.; Sanders, Elisabeth A.M.; Vlaminckx, Bart J.M.; de Melker, Hester E.; Schouls, Leo M.; de Greeff, Sabine C.; van der Ende, Arie;
    Corporate Author:
    on behalf of the Invasive Pneumococcal Disease Sentinel Surveillance Laboratory Group
    Published:
    Nov 2012
    Source:
    Emerg Infect Dis. 18(11):1729-1737.
    Description:
    In the Netherlands, the national immunization program includes 7-valent pneumococcal conjugate vaccine (PCV7) for all newborns born after April 1, 2006. We compared the incidence of invasive pneumococcal disease (IPD) and patient and disease characte...
    File Type:
    Filetype[PDF - 228.78 KB]
  2. Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 24-59 months who are not completely vaccinated.
    Source:
    MMWR. Morbidity and mortality weekly report. 2008; 57(13):343-4.
    Description:
    This notice updates the recommendation for use of 7-valent pneumococcal conjugate vaccine (PCV7) among children aged 24-59 months who are either unvaccinated or who have a lapse in PCV7 administration. In February 2000, PCV7, marketed as Prevnar and ...
    Status:
    superseded
    File Type:
    Filetype[PDF - 319.43 KB]
  3. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Personal Author:
    Bennett, Nancy M.; Whitney, Cynthia G.; Moore, Matt.; Pilishvili, Tamara.; Dooling, Kathleen L.;
    Corporate Author:
    National Center for Immunization and Respiratory Diseases (U.S.); United States. Advisory Committee on Immunization Practices. Pneumococcal Work Group;
    Published:
    2012 Oct 12
    Description:
    MMWR. Morbidity and mortality weekly report 2012 Oct 12;61(40):816-9. : Reported by: Nancy M. Bennett, MD, Advisory Committee on Immunization Practices Pneumococcal Work Group. Cynthia G. Whitney, MD, Matt Moore, MD, Tamara Pilishvili, MPH, Respirato...
    Status:
    current
    File Type:
    Filetype[PDF - 91.23 KB]
  4. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions : recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Personal Author:
    Bennett, Nancy M.; Whitney, Cynthia G.; Moore, Matt.; Pilishvili, Tamara.; Dooling, Kathleen L.;
    Corporate Author:
    National Center for Immunization and Respiratory Diseases (U.S.); United States. Advisory Committee on Immunization Practices.;
    Published:
    2012 Oct 12
    Description:
    On June 20, 2012, the Advisory Committee on Immunization Practices (ACIP) recommended routine use of 13-valent pneumococcal conjugate vaccine (PCV13; Prevnar 13, Wyeth Pharmaceuticals, Inc., a subsidiary of Pfizer, Inc.) for adults aged ≥19 years w...
    Status:
    current
    File Type:
    Filetype[PDF - 91.23 KB]
  5. Seven-Valent Pneumococcal Conjugate Vaccine and Nasopharyngeal Microbiota in Healthy Children
    Personal Author:
    Biesbroek, Giske; Wang, Xinhui; Keijser, Bart J.F.; Eijkemans, Rene M.J.; Trzciński, Krzysztof; Rots, Nynke Y.; Veenhoven, Reinier H.; Sanders, Elisabeth A.M.; Bogaert, Debby;
    Published:
    Feb 2014
    Source:
    Emerg Infect Dis. 20(2):201-210.
    Description:
    Seven-valent pneumococcal conjugate vaccine (PCV-7) is effective against vaccine serotype disease and carriage. Nevertheless, shifts in colonization and disease toward nonvaccine serotypes and other potential pathogens have been described. To underst...
    File Type:
    Filetype[PDF - 821.56 KB]